Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry
NCT07691034
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Minimal Residual Disease
Interventions
DIAGNOSTIC_TEST:
Mass spectrometry
Sponsor
Odense University Hospital